Clinical trial

Study of Picoplatin Efficacy After Relapse

NCT00465491

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE3

Study timeline

Study start (unknown)2007-04-01Date precision: month

Registry last updated2009-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Interventions

picoplatinDRUG

best supportive careOTHER

Sponsors & collaborators

Poniard Pharmaceuticalslead sponsor

Mapped research locations

Buenos AiresArgentina7 Saint PetersburgRussia4 MoscowRussia3 BucharestRomania2 VarnaBulgaria2 KrakowPoland1 SofiaBulgaria1 PoznanPoland1 BydgoszczPoland1 PlovdivBulgaria1 CórdobaArgentina1 Cluj-NapocaRomania1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00465491 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.